The Impact of Viral Coinfections in Respiratory Tract Infections: Epidemiology, Pathophysiology and Clinical Implications

Alberto Gori^*
*Correspondence: Alberto Gori, Department of Infectious Diseases, L. Sacco University Hospital, ASST Fatebenefratelli-Sacco, 20122 Milano, Italy, Email:

Introduction

Respiratory tract infections are one of the most common reasons for medical visits, hospital admissions, and mortality worldwide, particularly among vulnerable populations such as young children, the elderly, and individuals with underlying health conditions. These infections, caused by a variety of pathogens, can be classified into upper respiratory tract infections such as the common cold and sinusitis, and lower respiratory tract infections, including pneumonia, bronchitis, and bronchiolitis. The pathogens responsible for these infections can be viral, bacterial, or a mix of both. In recent years, a growing body of evidence has highlighted the importance of viral coinfections, which can complicate the clinical course of RTIs, lead to more severe disease, and increase the risk of complications. Viral coinfections occur when a patient is infected with more than one respiratory virus simultaneously, which can lead to a more severe and prolonged illness. Studies have shown that coinfections can affect both the severity and outcomes of RTIs, with certain combinations of viruses leading to greater morbidity and mortality. This article will explore the burden of viral respiratory tract infection coinfections, the associated risk factors, the pathophysiology behind these coinfections, and their implications for clinical practice. Viral respiratory tract infections are caused by a wide array of viruses, and they are primarily responsible for both upper and lower RTIs [1,2].

Description

Influenza is a major cause of seasonal epidemics and can lead to severe complications such as pneumonia and respiratory failure, particularly in high-risk groups like the elderly, young children, and immunocompromised individuals. Adenovirus infections can lead to a variety of illnesses, including URTIs, conjunctivitis, and more severe conditions like pneumonia. Coronaviruses, including SARS-CoV-2, cause both upper and lower RTIs and have been associated with significant morbidity and mortality, particularly during the ongoing COVID-19 pandemic. These viruses, including coxsackievirus and echovirus, can cause a range of respiratory and gastrointestinal diseases. While viral infections are typically self-limiting, they can lead to more severe complications when coinfections occur. Coinfection refers to the simultaneous presence of two or more pathogens in the same patient, which can complicate the clinical picture. Viral coinfections in respiratory tract infections are particularly concerning, as they have been associated with worse clinical outcomes, prolonged illness, and an increased risk of bacterial superinfection. In studies examining children and adults with acute respiratory infections, viral coinfections have been found to be common. Respiratory viruses such as RSV, influenza, and rhinovirus are frequently involved in coinfections. Some studies have suggested that coinfections, particularly those involving influenza and RSV, are associated with higher mortality rates, especially in the very young, elderly, and immunocompromised populations [3-5].

Conclusion

Individuals with underlying respiratory diseases, such as asthma, chronic obstructive pulmonary disease or cystic fibrosis, are at increased risk for both viral infections and coinfections. These conditions compromise the integrity of the respiratory tract and immune system, making patients more vulnerable to viral pathogens. Patients with weakened immune systems, including those undergoing chemotherapy, organ transplant recipients, or individuals with HIV/AIDS, are more prone to viral infections and subsequent coinfections. Their immune systems may struggle to mount an effective response to multiple viral invaders. Patients with influenza who are subsequently infected with another respiratory virus such as RSV or rhinovirus are at higher risk for more severe illness. During periods of high viral activity, when multiple respiratory viruses are circulating within the community, the risk of coinfection increases. This is particularly common during seasonal outbreaks such as the flu season, when influenza, RSV, and rhinovirus infections are prevalent.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Cui, Chendi, Tristan T. Timbrook, Cate Polacek and Zoe Heins, et al. "Disease burden and high-risk populations for complications in patients with acute respiratory infections: A scoping review." Front Med 11 (2024): 132-5236.

Google Scholar, Crossref, Indexed at

2. Ruuskanen, Olli, Elina Lahti, Lance C. Jennings and David R. Murdoch. "Viral pneumonia." Lancet 377 (2011): 1264-1275.

Google Scholar

3. Aliberti, Stefano, Luis F. Reyes, Paola Faverio and Giovanni Sotgiu, et al. "Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): An international, observational cohort study." Lancet Infect Dis 16 (2016): 1364-1376.

Google Scholar, Crossref, Indexed at

4. Radovanovic, Dejan, Giovanni Sotgiu, Mateja Jankovic and Padukudru Anand Mahesh, et al. "An international perspective on hospitalized patients with viral community-acquired pneumonia." Eur J Intern Med 60 (2019): 54-70.

Google Scholar, Crossref, Indexed at

5. Santus, Pierachille, Dejan Radovanovic, Maria Rita Gismondo and Sara Giordana Rimoldi, et al. "Respiratory syncytial virus burden and risk factors for severe disease in patients presenting to the emergency department with flu-like symptoms or acute respiratory failure." Respir Med 218 (2023): 107404.

Google Scholar, Crossref, Indexed at